Comparing two plasma exchange doses for acute liver failure with brain swelling
Part of Brain & nervous system, Digestive system, Infections clinical trials.
This study compares giving a higher versus a standard amount of plasma exchange, a treatment that cleans your blood, to see if it helps people with sudden liver failure and brain swelling. It aims to find out if a higher dose can better reduce brain pressure and improve outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have sudden liver failure, meaning jaundice with confusion and bleeding problems within 4 weeks, without prior liver disease.
- You have brain swelling seen on a CT scan and high ammonia levels in your blood.
- You are between 18 and 70 years old.
- You do not have liver cancer, active infections, or severe bleeding problems.
- You are not pregnant or have liver failure from drugs or after surgery.
- You are not critically ill with very low blood pressure or severe lung problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a higher volume of plasma exchange (cleaning the blood to remove toxins) works better than the standard amount for children with acute liver failure who are not improving with usual care.
This study tests whether doing plasma exchange (a treatment that cleans the blood) every day works better than every other day for children with Wilson disease and acute liver failure. It may help your child's liver recover by removing harmful copper and waste products from the blood.
This trial tests if a higher intensity of continuous dialysis (CRRT) better lowers ammonia levels in patients with liver failure. It aims to find the best approach to reduce brain complications from high ammonia.
This trial tests whether a treatment called plasma exchange (which removes harmful substances from your blood and replaces them with healthy plasma) can help improve the function of other organs, like the kidneys or lungs, in people with advanced liver failure. It aims to find out if this treatment helps you recover better and to identify markers that show if the treatment is working.
This study compares a blood-filtering treatment called therapeutic plasma exchange with standard medicines for people with severe autoimmune hepatitis. It aims to see if plasma exchange can improve outcomes when a liver transplant is not available soon.
This trial tests whether a treatment called plasmapheresis (plasma exchange) can help people with severe liver damage caused by medications when they also have chronic liver disease. The treatment filters the blood to remove harmful substances, which may improve liver function and recovery.
Hear when a new Acute Liver Failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.